FYI. Call for abstracts
This special issue of Fat Studies: An Interdisciplinary Journal of Body Weight and Society explores fatness and anti-fatness as they relate to the emerging medical application of GLP-1 agonists, a class of drugs (including Ozempic, Wegovy, and Mounjaro), for weight loss. From a fat studies perspective, GLP-1s are fraught with ethical, moral, and existential tensions for fatness and fat people (Oswald, 2024).
The goal of this special issue is to center critical social science and humanities-based perspectives on the relationships between fatness and GLP-1s, especially how these relationships are mediated by sexuality, race/ethnicity, class, disability, age, gender identity, and other axes of identity. This special issue will prioritize submissions that use a critical fat studies lens, and will not consider work that solely adopts a medical perspective. We are particularly interested in work that utilizes an intersectional framework and focuses on fat people’s lived experiences.
More information: https://think.taylorandfrancis.com/special_issues/glp-1s-and-anti-fatness/
Deadline for abstract submission: 1 March, 2025
Deadline for full manuscripts: 15 June, 2025